CCL21 and neoplasm: 60% of mice treated with DC-CCL21 weekly for three weeks showed complete lung tumor eradication, in contrast, only12% mice treated with controlled DC showed tumor rejection and mice with recombinant CCL21 injection at similar dose showed no anti-tumor effect [9].